Understand · Treat · Recover

Screening and Early Detection

Screening looks for disease before symptoms appear. A persistent or suspicious symptom needs diagnostic evaluation, even after a recent normal check-up.

Patient education only. This guide does not diagnose cancer or prescribe treatment. Your team must adapt decisions to your cancer, health, preferences and local resources.

All 25 chapters

Chapter 6 of 25

Oral self-awareness: look, notice, report
  1. In good light, look at the lips and gently turn them outward
  2. Look at the cheek lining and gums without scraping lesions
  3. Look at the tongue surfaces and beneath it only as comfortable
  4. Note a persistent ulcer, red or white patch, swelling or reduced opening
  5. Arrange examination: self-checking cannot inspect all throat sites or exclude cancer

Screening is different from diagnosis

A screening test is offered to someone without symptoms, usually because a defined population may benefit. Diagnostic evaluation investigates a symptom, lesion or abnormal screening result. A person with a persistent ulcer should not wait until a future screening camp: the ulcer already provides a reason for assessment.

There is no single screening test that reliably covers every head and neck cancer. A visual mouth examination cannot fully inspect the base of tongue, voice box or areas behind the nose. A normal result is reassuring about what was examined on that day, not a lifetime guarantee.

What is and is not established

Routine universal screening for all head and neck cancers is not an established standard. Targeted oral visual examination by trained workers is used in some high-risk settings, including programmes relevant to India. Its purpose is to identify suspicious changes that need further evaluation, not to diagnose cancer from appearance alone.

The evidence and implementation differ by population and cancer site. NCI notes limitations in evidence for general population screening, while IARC considers evidence for clinical oral examination in high-risk populations. These statements are not interchangeable recommendations for everyone to undergo PET-CT, endoscopy or an HPV mouth swab. Follow the locally appropriate prevention programme and seek diagnostic assessment for symptoms.

What a clinician or dentist looks for

A trained examiner inspects the lips, cheeks, gums, tongue, floor of mouth and palate and may feel the neck and suspicious tissues. A dental visit can identify tooth and gum problems and provide an opportunity to notice abnormal lining. The examiner asks about duration, previous lesions, tobacco, areca use and other relevant history.

Not every white patch needs the same response. A likely reversible cause may be addressed with a defined reassessment plan. A suspicious lesion may need prompt biopsy. Devices that use special light or dyes can sometimes assist examination, but they do not replace a good clinical assessment or tissue diagnosis when indicated.

Leukoplakia and erythroplakia

Leukoplakia describes a white patch after other identifiable causes have been considered. Erythroplakia describes a red patch without another clear explanation. These are clinical descriptions, not a final microscopic diagnosis. A patch can contain no dysplasia, varying degrees of dysplasia or an established cancer; biopsy helps clarify this.

Dysplasia means that cells look abnormal and show disordered development. It is not the same as invasive cancer, but it can affect management and follow-up. A lesion that changes colour, thickens, ulcerates, becomes painful or enlarges needs reassessment. Removing a lesion does not necessarily remove the need for later checks, especially if harmful exposures continue.

Oral submucous fibrosis

In oral submucous fibrosis, tissues in the mouth become scarred and less flexible. Burning, sensitivity and reduced mouth opening can make meals and oral care difficult. Areca-nut exposure is a major concern, including products without tobacco. The condition has malignant potential, so persistent monitoring is important.

Stopping areca and tobacco use is a central step. Treatment for symptoms and mouth opening should be supervised; do not force stretching or assume that a supplement cures the underlying risk. Report a new ulcer, lump or change within a previously diagnosed condition promptly rather than waiting for the next routine visit.

A gentle oral self-awareness routine

In good light, look at the outside and inside of the lips. Gently pull each cheek aside to notice its lining. Look at the gums and roof of the mouth, then the visible top and sides of the tongue. Lift the tongue gently to see the floor of the mouth if comfortable. Notice changes rather than trying to make a diagnosis.

Do not scrape patches, puncture lumps or force the mouth open. The back of the throat and deeper tissues cannot be reliably assessed at home. Seek care for an unfamiliar persistent change, a firm lump or unexplained bleeding. Self-awareness supports timely care; it is not a substitute for professional examination and does not rule out hidden cancer.

Making early detection useful

Follow-through matters more than simply attending a screening event. Ask who will arrange any referral, where a biopsy can be performed and how results will be communicated. Keep copies of the referral and report. If an appointment cannot be obtained promptly, contact the referring service rather than assuming a delay is harmless.

Early detection works alongside prevention: stop tobacco and areca products, address alcohol exposure and follow appropriate vaccination advice. Do not pay for repeated “whole-body cancer screening” scans without a clear clinical indication. Additional testing can cause false alarms and unnecessary procedures without reliably preventing advanced disease.

References and evidence review

Evidence/editorial check: 25 October 2026. AI-assisted preparation is distinct from individual physician review. See the linked review policy for source-access limits and review status. Regulatory indications, reimbursement and availability vary by country. Trial results alone do not establish approval everywhere; your treating team should confirm the applicable current guidance.